GLUCURONIDATION OF SARPOGRELATE ACTIVE METABOLITE (M1) IS MEDIATED BY UDP-GLUCURONOSYLTRANSFERASES 1A4, 1A9 AND 2B4

被引：0
|
作者：
Kim, Dong-Hyun [1 ,2 ]
Shin, Jae-Gook [1 ,2 ]
Kim, Hyo-Ji [1 ,2 ]
Jeong, Eun-Sook [1 ,2 ]
Seo, Kyung-Ah [1 ,2 ]
Shin, Jae-Gook [1 ,2 ]
Kim, Dong-Hyun [1 ,2 ]
机构：
[1] Inje Univ, Coll Med, Dept Pharmacol, Pusan, South Korea
[2] Inje Univ, Coll Med, PharmacoGen Res Ctr, Pusan, South Korea
来源：
DRUG METABOLISM REVIEWS | 2012年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1.
    Rios, GR
    Tephly, TR
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1364 - 1367
  • [22] Production of human UDP-glucuronosyltransferases 1A6 and 1A9 using the Semliki Forest virus expression system
    Forsman, T
    Lautala, P
    Lundström, K
    Monastyrskaia, K
    Ouzzine, M
    Burchell, B
    Taskinen, J
    Ulmanen, I
    LIFE SCIENCES, 2000, 67 (20) : 2473 - 2484
  • [23] Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS
    Joo, Jeongmin
    Kim, Yang-Weon
    Wu, Zhexue
    Shin, Jung-Hoon
    Lee, Boram
    Shon, Jong Cheol
    Lee, Eun Young
    Nguyen Minh Phuc
    Liu, Kwang-Hyeon
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (04) : 258 - 264
  • [24] Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7
    Cheng, ZQ
    Rios, GR
    King, CD
    Coffman, BL
    Green, MD
    Mojarrabi, B
    Mackenzie, PI
    Tephly, TR
    TOXICOLOGICAL SCIENCES, 1998, 45 (01) : 52 - 57
  • [25] Identification of UDP-glucuronosyltransferases 1A1, 1A3 and 2B15 as the main contributors to glucuronidation of bakuchiol, a natural biologically active compound
    Li, Feng
    Wang, Shuai
    Lu, Danyi
    Wang, Yifei
    Dong, Dong
    Wu, Baojian
    XENOBIOTICA, 2017, 47 (05) : 369 - 375
  • [26] Effect of Efavirenz on UDP-Glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 Activities in Human Liver Microsomes
    Ji, Hye Young
    Lee, Hyeri
    Lim, Sae Rom
    Kim, Jeong Han
    Lee, Hye Suk
    MOLECULES, 2012, 17 (01): : 851 - 860
  • [27] Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4
    Kubota, Takahiro
    Lewis, Benjamin C.
    Elliot, David J.
    Mackenzie, Peter I.
    Miners, John O.
    MOLECULAR PHARMACOLOGY, 2007, 72 (04) : 1054 - 1062
  • [28] Genetic polymorphisms of UDP-glucuronosyltransferases in a healthy Korean population: UGT1A1, 1A6, 2B4, 2B7 and 2B15 subfamilies.
    Yim, D
    Yoon, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P41 - P41
  • [29] Bovine Serum Albumin Decreases Km Values of Human UDP-Glucuronosyltransferases 1A9 and 2B7 and Increases Vmax Values of UGT1A9
    Manevski, Nenad
    Moreolo, Paolo Svaluto
    Yli-Kauhaluoma, Jari
    Finel, Moshe
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2117 - 2129
  • [30] Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes
    Jiang, Lili
    Zhang, Zhongmin
    Xia, Yangliu
    Wang, Zhen
    Wang, Xiaoyu
    Wang, Shujuan
    Wang, Zhe
    Liu, Yong
    TOXICOLOGY LETTERS, 2020, 320 : 46 - 51
12345